The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world neo-adjuvant with or without adjuvant treatment patterns among pancreatic ductal adenocarcinoma patients in the U.S.
 
Prakash Navaratnam
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Merck (Inst); Sanofi (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Sanofi (Inst)
 
Monica Chase
Employment - Merck
Stock and Other Ownership Interests - Merck
Research Funding - Merck
Travel, Accommodations, Expenses - Merck
 
Howard Steven Friedman
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Merck (Inst); Sanofi (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Sanofi (Inst)
 
Seongjung Joo
Employment - Merck
Stock and Other Ownership Interests - Merck
Research Funding - Merck
Travel, Accommodations, Expenses - Merck
 
Michael J. Pishvaian
Stock and Other Ownership Interests - Perthera
Honoraria - Halozyme
Consulting or Advisory Role - ARMO BioSciences; AstraZeneca/MedImmune; Caris Life Sciences; Merck; Perthera; Rafael Pharmaceuticals; RenovoRx; Sirtex Medical
Research Funding - Abbvie (Inst); ARMO BioSciences (Inst); Bavarian Nordic (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celgene (Inst); Celldex (Inst); Curegenix (Inst); FibroGen (Inst); Genentech (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Halozyme (Inst); Karyopharm Therapeutics (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); Regeneron (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - Perthera patient matching algorithm; Use patent for veliparib and FOLFOX
Travel, Accommodations, Expenses - Merck; Perthera; Sirtex Medical